scholarly journals Improving Access to Information and Support for Patients With Less Common Cancers: Hematologic Cancer Patients’ Views About Web-Based Approaches

2011 ◽  
Vol 13 (4) ◽  
pp. e112 ◽  
Author(s):  
Christine Louise Paul ◽  
Mariko Leanne Carey ◽  
Alix Edna Hall ◽  
Marita Clare Lynagh ◽  
Robert W Sanson-Fisher ◽  
...  
2017 ◽  
Vol 33 (5) ◽  
pp. 1069-1074 ◽  
Author(s):  
Jordan G. Bruce ◽  
Jennifer L. Tucholka ◽  
Nicole M. Steffens ◽  
Jane E. Mahoney ◽  
Heather B. Neuman

2014 ◽  
Vol 75 (1) ◽  
pp. 41-47 ◽  
Author(s):  
Jessica R.L. Lieffers ◽  
Vivienne A. Vance ◽  
Rhona M. Hanning

Purpose A cross-sectional web-based survey of dietitians was used to explore topics related to mobile devices and their applications (apps) in Canadian dietetic practice. Methods A survey was drafted, posted on SurveyMonkey, and pretested with dietitians and dietetic interns. Dietitians of Canada (DC), a supporter of this work, promoted the survey to members through its monthly electronic newsletters from January 2012 to April 2012. Results Of 139 dietitians who answered some survey questions, 118 finished the survey; this represents a response rate of approximately 3%. Overall, 57.3% of respondents reported app use in practice, and 54.2% had a client ask about or use a nutrition/food app. About 40.5% of respondents had recommended nutrition/food apps to clients. Respondents were enthusiastic about apps, but many described challenges with use. From the survey data, three themes emerged that can affect dietitians’ use of apps and whether they recommend apps to clients: mobile device and app factors (access to information/ tools, content quality, usability, accessibility/compatibility, and cost), personal factors (knowledge, interest, suitability, and willingness/ability to pay), and workplace factors. Conclusions Apps are now infiltrating dietetic practice. Several factors can affect dietitians’ use of apps and whether they recommend them to clients. These findings will help guide future development and use of apps in practice.


Author(s):  
Christine M. Newlon ◽  
Chin-Chun A. Hu ◽  
Renee M. Stratton ◽  
Anna M. McDaniel

2020 ◽  
Author(s):  
Emily G Lattie ◽  
Michael Bass ◽  
Sofia F Garcia ◽  
Siobhan M Phillips ◽  
Patricia I Moreno ◽  
...  

BACKGROUND Unmanaged cancer symptoms and treatment-related side effects can compromise long-term clinical outcomes and health-related quality of life. Health information technologies such as web-based platforms offer the possibility to supplement existing care and optimize symptom management. OBJECTIVE This paper describes the development and usability of a web-based symptom management platform for cancer patients and survivors that will be implemented within a large health system. METHODS A web-based symptom management platform was designed and evaluated via one-on-one usability testing sessions. The System Usability Scale (SUS), After Scenario Questionnaire (ASQ), and qualitative analysis of semistructured interviews were used to assess program usability. RESULTS Ten cancer survivors and five cancer center staff members participated in usability testing sessions. The mean score on the SUS was 86.6 (SD 14.0), indicating above average usability. The mean score on the ASQ was 2.5 (SD 2.1), indicating relatively high satisfaction with the usability of the program. Qualitative analyses identified valued features of the program and recommendations for further improvements. CONCLUSIONS Cancer survivors and oncology care providers reported high levels of acceptability and usability in the initial development of a web-based symptom management platform for cancer survivors. Future work will test the effectiveness of this web-based platform.


2017 ◽  
Vol 25 (12) ◽  
pp. 3675-3682 ◽  
Author(s):  
Maria Wiklander ◽  
Johanna Strandquist ◽  
Claire Micaux Obol ◽  
Lars E. Eriksson ◽  
Jeanette Winterling ◽  
...  

2021 ◽  
Author(s):  
Shereef Elsamany ◽  
Mohamed Elbaiomy ◽  
Ahmed Zeeneldin ◽  
Emad Tashkandi ◽  
Fayza Hassanin ◽  
...  

BACKGROUND Management of cancer patients in the current era of COVID-19 pandemic poses a significant challenge on health care systems. OBJECTIVE We explored the views of oncologists for the management of breast cancer patients during COVID-19 pandemic. METHODS A web-based questionnaire using SurveyMonkey was submitted to licensed oncologists involved in breast cancer management in Saudi Arabia, Egypt and United Arab Emirates. The survey focused on characteristics of participants, infection risk among cancer patients and possible treatment modifications related to different types of breast cancer RESULTS The survey was completed by 82 participants. For early HR positive, HER2-negative breast cancer,74.4% supported using neoadjuvant hormonal therapy in selected patients, and 58.0% preferred giving 6 over 8 cycles of adjuvant chemotherapy when indicated. Only 42.7% preferred CDK4/6 inhibitor with hormonal therapy as first line in all patients with metastatic HR-positive disease. 67.1% of participants supported using adjuvant trastuzumab for 6 instead of 12 months in selected patients with HER2-positive breast cancer. For metastatic HER2-positive, HR-positive breast cancer, 80.5% of participants supported the use of hormonal therapy with dual anti-HER2 blockade in selected patients. The preferred choice of 1st line treatment in metastatic triple negative patients with BRCA mutation and PDL1<1%, was PARP inhibitor according to 42.5% of the participants, and atezolizumab with nabpaclitaxel if the PDL1>1% according to 70.4% of the participants. CONCLUSIONS Several modifications in breast cancer management is supported by the survey participants. These modifications need to be discussed on local basis taking into account the local infrastructure and available resources. CLINICALTRIAL none


Sign in / Sign up

Export Citation Format

Share Document